RESVERLOGIX CORP. (RVX.TO)
Develops a drug to treat heart disease, kidney disease, and diabetes complications.
0.10-0.05%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago+0.0%
The outlook
RVX.TO is trading near its 52-week lows, sitting just 17% above the bottom of its yearly range. The stock shows mixed momentum against its moving averages, and analyst sentiment leans bearish overall. Current data suggests a challenging picture for the company's near-term outlook.
What’s behind the score
Price trendMixed vs its moving averages
52-week range17% of the way from its 52-week low to high
Market cap
—
52-wk high
0.15
52-wk low
0.09
50-day avg
0.10
200-day avg
0.11
Trailing P/E
—